Oncology News | pharmaphorum

News

EU regulator backs Idorsia’s Quviviq for adults with insomni...

A new treatment for adults with insomnia disorder has been recommended for use in Europe, giving hope to people whose lives are blighted by the condition.

News

Babraham Institute makes breakthrough in early human embryo ...

A new stem cell model, discovered by researchers exploring the human genome, will help scientists to map out the key genomic changes during early development.

News

GSK’s ZEJULA gets green light for NHS use

The UK’s National Institute for Health and Care Excellence (NICE) has recommended GlaxoSmithKline’s (GSK) ZEJULA (niraparib) for some forms of ovarian, fallopian tube, and peritoneal cancer

News

Cantex secures license to develop small molecule-drug for in...

Clinical stage pharmaceutical company Cantex Pharmaceuticals has obtained a global licence from Harvard University’s Office of Technology Development to develop the small-molecule drug azel

News

Big day for AZ, Daiichi as Enhertu aces HER2-low breast canc...

Already making inroads as a treatment for HER2-positive breast cancer, AstraZeneca and Daiichi Sankyo's Enhertu has now shown efficacy in tumours that express lower levels of HER2 – potenti

News

Amgen eyes pancreatic cancer use for its pathfinder KRAS dru...

Armed with new clinical trial results, Amgen is expanding studies of its KRAS inhibitor Lumakras in pancreatic cancer, as it tries to extend the label for the first-in-class drug beyond its

EU regulator backs Idorsia’s Quviviq for adults with insomni...

Babraham Institute makes breakthrough in early human embryo ...

GSK’s ZEJULA gets green light for NHS use

Cantex secures license to develop small molecule-drug for in...

Big day for AZ, Daiichi as Enhertu aces HER2-low breast canc...

Amgen eyes pancreatic cancer use for its pathfinder KRAS dru...

UK Knowledge Quarter welcomes Boehringer Ingelheim AI accele...

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks